EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastomaNina Struve, Malte Kriegs|Oncogene|2020Cited by 67
G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cellsMeryem Cetin, Nina Struve|Radiation Oncology|2023Cited by 11